Philly NavSTAR Implementation Trial
Key facts
- Who runs it
- Friends Research Institute, Inc.
- Where
- Philadelphia, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 9 Aug 2024
- Ended
- 31 Aug 2025
- Type of study
- Interventional
- Treatments tested
- NavSTAR (Philly adaptation)
- Record updated
- 29 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- age 18 or older
- current DSM-5 criteria for moderate to severe OUD
- willing and able to provide informed consent in English
Who cannot take part
- enrollment in OUD treatment 30-days prior to hospitalization
- residency outside the City of Philadelphia
- pregnancy
- planned discharge to a long-term inpatient care facility (e.g., hospice)
- hospitalization for a suicide attempt
Where in United States
- Friends Research InstitutePhiladelphia, United States
- Jefferson HealthPhiladelphia, United States
About the trial
What the trial wants to find out
Patient Navigation (PN) interventions following hospitalization can reduce the differences that certain groups have been trying to access opioid use disorder treatment. These differences, which affect racial minority groups the most, contribute to the opioid overdose epidemic. However, delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to find solutions to these significant barriers by engaging community, hospital, and patient partners. This study is being conducted to learn more about how to implement NavSTAR, a patient navigation intervention for people with opioid use disorder, across a health system. Our research team showed in a previous study with 400 participants that NavSTAR significantly increased entry into opioid use disorder treatment, reduced readmissions to the hospital, and was highly cost- effective compared to treatment as usual. This study will first pilot NavSTAR with 32 patient participants across 4 hospitals in the City of Philadelphia. Then, we will conduct a large trial with 720 patient participants to see if we can reach people who need the intervention, and create a sustainable plan to continue the intervention after the grant award period.
The group in the trial
- NavSTARTreatment being tested
NavSTAR is a Patient Navigation service model to reduce internal and external barriers to recommended service engagement. It includes motivational interventions in tandem with proactive barrier resolution, targeting areas of addiction, medical, self-care, and basic needs.
Treatment: NavSTAR (Philly adaptation)
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Implementing a Patient Navigation Intervention Across a Health System to Address Treatment Entry Inequities
- Record updated
- 29 September 2025